IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.

Recall Number: D-0765-2022

Firm: Teva Pharmaceuticals USA Inc

Classification: Class I

Status: Terminated

Report Date: 20220420

Initiation Date: 20220329

Termination Date: 20230620

Presence of Particulate Matter: Product was found to contain silica and iron oxide

IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North Wales, PA 19454, NDC 0703-4154-11.